› Forums › General Melanoma Community › Genentech pdl?
- This topic has 6 replies, 2 voices, and was last updated 13 years ago by
gep.
- Post
- Replies
-
-
- January 21, 2013 at 4:33 am
The only Genentech thing I've heard about recently is their anti-PD-L1 monoclonal antibdy. Is this the trial you mean?
Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors
-
- January 21, 2013 at 4:33 am
The only Genentech thing I've heard about recently is their anti-PD-L1 monoclonal antibdy. Is this the trial you mean?
Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors
-
- January 21, 2013 at 4:33 am
The only Genentech thing I've heard about recently is their anti-PD-L1 monoclonal antibdy. Is this the trial you mean?
Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors
-
- You must be logged in to reply to this topic.